Liang Philip 的 Form 4/A 修正申報
修正Vicarious Surgical Inc.（RBOT），2023/2/9 申報
- 申報編號
- 0001213900-23-009900
- 申報時間
- 2023/2/9
- 交易日
- 2023/2/6
- 申報延遲
- 3 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2023/2/8
這份申報列了 1 筆非衍生性交易。公開市場買進合計 $8.18 萬。交易後 3 天申報。
這份修正申報取代了 0001213900-23-009493（2023/2/8 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Liang PhilipCIK 0001883781 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/2/6 | Class A Common Stock | P買進取得 | +26,811 | $3.05F2 | +$81,773.55 | 26,811 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.
- F2
This figure is the weighted average sales price of multiple trades ranging from $3.02 to $3.0609 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.
- F4
Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.
- F5
Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein.
備註
On February 8, 2023, the Reporting Person filed a Form 4 which inadvertently reported a transaction directly by the Reporting Person. In fact, the reported transaction was by E15 Fund III, LP, an entity affiliated with the Reporting Person, as reported in this amendment. This Form 4 amendment is intended to replace, in its entirety, the Form 4 filed on February 8, 2023.